Denali Therapeutics, Inc. (DNLI)
21.34
+0.73
(+3.54%)
USD |
NASDAQ |
Jun 11, 13:36
Denali Therapeutics Accounts Payable (Quarterly) : 40.38M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 40.38M |
| December 31, 2025 | 3.33M |
| September 30, 2025 | 6.745M |
| June 30, 2025 | 10.84M |
| March 31, 2025 | 8.458M |
| December 31, 2024 | 11.14M |
| September 30, 2024 | 9.594M |
| June 30, 2024 | 13.94M |
| March 31, 2024 | 11.86M |
| December 31, 2023 | 9.483M |
| September 30, 2023 | 1.182M |
| June 30, 2023 | 8.52M |
| March 31, 2023 | 2.215M |
| December 31, 2022 | 2.79M |
| September 30, 2022 | 7.539M |
| June 30, 2022 | 7.116M |
| March 31, 2022 | 3.358M |
| December 31, 2021 | 4.779M |
| September 30, 2021 | 4.817M |
| Date | Value |
|---|---|
| June 30, 2021 | 4.235M |
| March 31, 2021 | 1.626M |
| December 31, 2020 | 1.071M |
| September 30, 2020 | 2.806M |
| June 30, 2020 | 1.866M |
| March 31, 2020 | 2.316M |
| December 31, 2019 | 2.59M |
| September 30, 2019 | 2.022M |
| June 30, 2019 | 3.931M |
| March 31, 2019 | 3.662M |
| December 31, 2018 | 1.891M |
| September 30, 2018 | 3.354M |
| June 30, 2018 | 9.176M |
| March 31, 2018 | 1.377M |
| December 31, 2017 | 2.716M |
| September 30, 2017 | 2.27M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 1.963M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 70.38M |
| ImmunityBio, Inc. | 11.19M |
| Summit Therapeutics, Inc. | 27.55M |
| Arrowhead Pharmaceuticals, Inc. | 30.75M |
| Biogen, Inc. | 358.50M |